This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigations of heavy menstrual bleeding

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Consider starting pharmacological treatment for HMB without investigating the cause if the woman's history and/or examination suggests a low risk of fibroids, uterine cavity abnormality, histological abnormality or adenomyosis (1).

If cancer is suspected then consult urgent gynaecological cancer guidance (linked below).

  • laboratory investigations
    • blood tests
      • full blood count - should be undertaken on all women with heavy menstrual bleeding (HMB)
      • clotting studies - testing for coagulation disorders such as von Willebrand's disease should be considered in women who have had HMB since menarche and have personal or family history suggesting a coagulation disorder
      • serum ferritin test should not routinely be carried out on women with HMB - undertaken if the woman has been found to be anaemic on full blood count
      • female hormone testing should not be carried out on women with HMB
      • TFTs should be undertaken only when other signs and symptoms of thyroid disease are present (1)
    • cervical smear if indicated
    • HVS, chlamydia screen if infection suspected

  • structural and histological investigations
    • for suspected cancer guidance then see linked item
      • if appropriate, a biopsy should be taken to exclude endometrial cancer or atypical hyperplasia
        • indications for a biopsy include, for example, persistent intermenstrual bleeding, and, in women aged 45 and over, treatment failure or ineffective treatment
      • imaging studies are indicated in various circumstances:
        • if the uterus is palpable abdominally
        • vaginal examination reveals a pelvic mass of uncertain origin
        • failure of pharmaceutical treatment
        • ultrasound is the first-line diagnostic tool for identifying structural abnormalities
  • hysteroscopy - used as a diagnostic tool only when ultrasound results are inconclusive, for example, to determine the exact location of a fibroid or the exact nature of the abnormality
  • dilatation and curettage alone should not be used as a diagnostic tool

Note:

  • pregnancy test
    • pregnancy should be considered as a cause for an acute onset unexplained HMB
  • take into account the woman's history and examination when deciding whether to offer hysteroscopy or ultrasound as the first-line investigation
    • Women with suspected submucosal fibroids, polyps or endometrial pathology
      • outpatient hysteroscopy should be offered to women with HMB if their history suggests submucosal fibroids, polyps or endometrial pathology because:
        • they have symptoms such as persistent intermenstrual bleeding or
        • they have risk factors for endometrial pathology:
          • women with persistent intermenstrual or persistent irregular bleeding, and
          • women with infrequent heavy bleeding who are obese or have polycystic ovary syndrome
          • women taking tamoxifen women for whom treatment for HMB has been unsuccessful
        • endometrial biopsy should be considered at the time of hysteroscopy for women who are at high risk of endometrial pathology
      • for women who decline hysteroscopy, consider pelvic ultrasound, explaining the limitations of this technique for detecting uterine cavity causes of HMB

    • Women with possible larger fibroids
      • pelvic ultrasound should be offered to women with HMB if any of the following apply:
        • their uterus is palpable abdominally
        • history or examination suggests a pelvic mass
        • examination is inconclusive or difficult, for example in women who are obese

    • Women with suspected adenomyosis
      • transvaginal ultrasound (in preference to transabdominal ultrasound or MRI) should be offered to women with HMB who have:
        • significant dysmenorrhoea (period pain) or
        • a bulky, tender uterus on examination that suggests adenomyosis
      • if a woman declines transvaginal ultrasound or it is not suitable for her, consider transabdominal ultrasound or MRI, explaining the limitations of these techniques
      • be aware that pain associated with HMB may be caused by endometriosis rather than adenomyosis

Reference:

  1. Heavy menstrual bleeding: assessment and management. NG88. NICE Guideline (March 2018 - updated May 2021)

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.